TD Cowen has lowered Eli Lilly’s price target from $1,050 to $960, but maintained a Buy rating, citing solid long-term ...

Eternal shares up more than 5% intraday, as investor confidence returned following a bullish note from Morgan Stanley.

Erste Group has downgraded Eli Lilly from a buy to a hold rating due to concerns about its earnings forecast. Despite 36.38% ...

Now, let's return to our question: Should you invest $1,000 in Lilly right now? The shares are trading for 34 times forward ...

Tiger Global's tech-focused portfolio hits $26.59B with Meta, Microsoft, and Amazon leading. Discover new positions and ...

This was the stock's fifth consecutive day of gains.

Although as of this week the stock has declined by more than 4% since the start of the year, there's little reason to believe ...

Erin McCarthy wrote about emerging markets for The Wall Street Journal and Dow Jones Newswires, covering foreign exchange, fixed income and broader investment trends. She is also the creator and host ...

BMO Capital Markets reiterated its Outperform rating on Eli Lilly and Company (NYSE:LLY), setting a price target of $900 ...

Sensex crashes 800 points, Nifty nears 24,500, why is the Indian stock market falling? Monday’s market session didn’t just ...

RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark ...

Healthcare has been a tough sector in 2025. It looks like Q2 could be the low point for healthcare earnings growth for this ...